We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

iCAD

Offers a comprehensive range of upgradeable computer aided detection (CAD) and workflow solutions to support rapid an... read more Featured Products: More products

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

AI Technology for Detecting Breast Cancer Receives CE Mark Approval

By MedImaging International staff writers
Posted on 17 Jul 2019
Print article
Image: ProFound AI for 2D Mammography analyzes each mammography image and provides insight into each individual case (Photo courtesy of iCAD).
Image: ProFound AI for 2D Mammography analyzes each mammography image and provides insight into each individual case (Photo courtesy of iCAD).
iCAD, Inc. (Nashua, NH, USA), a provider of cancer detection and therapy solutions, has received CE Mark approval for its artificial intelligence (AI) technology and workflow solution, ProFound AI for 2D Mammography. The technology is the latest addition to iCAD’s deep-learning ProFound AI platform, joining ProFound AI for Digital Breast Tomosynthesis (DBT), which was CE Marked in March 2018, FDA-cleared in December 2018, and Health Canada licensed in July 2018. The technology has been developed to support the detection of breast cancer through the identification of soft tissue densities and calcifications.

ProFound AI for 2D Mammography is a high-functioning, deep-learning algorithm that analyzes each mammography image and provides critical insight into each individual case, such as highlighting the most suspicious areas and assigning unique Certainty of Finding and Case Scores, which can assist radiologists in making clinical decisions and prioritizing caseloads. The ProFound AI platform is built upon the latest in deep-learning AI and allows for continuously improved performance via ongoing software updates.

“Europe contains 9% of the world’s population but has more than 23% of the global cancer burden, with breast cancer being the most common cancer among European women,” said Stacey Stevens, President of iCAD. “This CE Mark further validates our ProFound AI platform as a world-class artificial intelligence solution that offers benefits to both radiologists and screening-aged women in detecting breast cancer. iCAD is committed to improving patient care worldwide and we are pleased to offer this powerful technology to a growing number of hospitals, imaging centers and women across Europe.”

“ProFound AI for 2D Mammography has the potential to assist radiologists in their interpretation of 2D mammography images, as we have seen with ProFound AI for DBT,” said Axel Gräwingholt, MD, Radiologie am Theater, in Paderborn, Germany. “As breast cancer rates continue to rise, it is imperative for radiologists to find cancers sooner, when they may be more easily treated, with fewer callbacks and false positives, which can be inconvenient and stressful for patients.”

Gold Supplier
Ultrasound Transducer/Probe Cleaner
Transeptic Cleaning Solution
New
Ultrasound System
HERA W10 Elite
New
Data Management Platform
Track-it
New
Mobile Surgical Fluoroscopy System
TCA 7

Print article

Channels

MRI

view channel
Image: New scan measures tumor oxygen levels in real-time to help guide treatment (Photo courtesy of ICR)

Oxygen-Enhanced MRI Technology Allows Cancer Doctors to See Inside Tumors

Since the 1950s, researchers have been aware of the difficulty in effectively treating tumors deprived of oxygen, a problem that is further exacerbated when treating them with radiotherapy.... Read more

Ultrasound

view channel
Image: New focused ultrasound is effective for treating Parkinson’s, movement disorders (Photo courtesy of Pexels)

New Focused Ultrasound Treatment Proves Effective for Parkinson’s Disease Patients

Parkinson's disease is a neurological condition characterized by the loss of dopamine neurons within the brain. While medications such as levodopa can be effective in managing this condition, some patients... Read more

Nuclear Medicine

view channel
Image: Tracking radiation treatment in real time promises safer, more effective cancer therapy (Photo courtesy of Pexels)

Real-Time 3D Imaging Provides First-of-Its-Kind View of X-Rays Hitting Inside Body During Radiation Therapy

Radiation is used in treatment for hundreds of thousands of cancer patients each year, bombarding an area of the body with high energy waves and particles, usually X-rays. The radiation can kill cancer... Read more

General/Advanced Imaging

view channel
Image: Viz.ai is the first to receive FDA 510(k) clearance for an AI algorithm for abdominal aortic aneurysm (Photo courtesy of Pexels)

AI Algorithm Flags and Triages Suspected Abdominal Aortic Aneurysms from Chest CT Scans

An abdominal aortic aneurysm (AAA) denotes a bulge in the abdominal aorta, the chief artery that transfers blood from the heart to other parts of the body. If not detected and treated in time, AAA can... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.